Jay Harper
Director, Oncology Targeted Discovery AstraZeneca
Seminars
Monday 12th October 2026
Unlocking the Therapeutic Power of Rationale-Driven ADC Combinations
Monday 12th October 2026
Combining the Past, Present & Future: Learnings, Trends & Impact of the Past 10 Years of ADC Combination Therapies
9:30 am
- Giving a retrospective view to highlight the growth and make-up of ADC combinations over the past ten years
- Understanding the highs and lows of ADC combinations: What has been the most impactful to patients?
- Evaluating the current landscape and future directions of ADC combinations to combat payload resistance and push ADCs to earlier line therapies
Tuesday 13th October 2026
Panel Discussion: What’s the New Path to the Next Generation of ADCs?
3:30 pm
- Understanding how to migrate from non-selective ADC payloads
- Debating the right properties for a next-generation payload and linker: Can (or should?) any small molecule therapeutic be developed into an ADC?
- Debating the right strategy for dual payload ADCs
- Understanding ADC toxicity and developability for next generation conjugates
